Sight Sciences, Inc. (SGHT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 30M 60M 90M Q3 '21: 43.3M Q4 '21: 49M Q1 '22: 55.2M Q2 '22: 59.9M Q3 '22: 65.5M Q4 '22: 71.3M Q1 '23: 75.3M Q2 '23: 81.5M Q3 '23: 82.8M Q4 '23: 81.1M Q1 '24: 81.5M Q2 '24: 79.4M Q3 '24: 79.5M Q4 '24: 79.9M Q1 '25: 78.1M Q2 '25: 76.3M Q3 '25: 76.1M Q4 '25: 77.4M Q1 '26: 79.6M Q2 '26: 83.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 25M 50M 75M Q3 '21: 34.2M Q4 '21: 40.3M Q1 '22: 45.9M Q2 '22: 50.1M Q3 '22: 54.8M Q4 '22: 59M Q1 '23: 62.9M Q2 '23: 68.5M Q3 '23: 70.1M Q4 '23: 69.2M Q1 '24: 69.9M Q2 '24: 68.1M Q3 '24: 67.7M Q4 '24: 68.3M Q1 '25: 66.9M Q2 '25: 65.1M Q3 '25: 65.4M Q4 '25: 66.7M Q1 '26: 68.5M Q2 '26: 73.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-90M -60M -30M 0 30M 60M 90M Q3 '21: -45.2M Q4 '21: -51.5M Q1 '22: -62M Q2 '22: -73.8M Q3 '22: -81.6M Q4 '22: -84M Q1 '23: -79.3M Q2 '23: -71.7M Q3 '23: -63.2M Q4 '23: -57.3M Q1 '24: -54.4M Q2 '24: -51.9M Q3 '24: -49.7M Q4 '24: -50.5M Q1 '25: -49.7M Q2 '25: -48.7M Q3 '25: -45.4M Q4 '25: -37.1M Q1 '26: -35.7M Q2 '26: -27.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-90M -60M -30M 0 30M 60M 90M Q3 '21: -56.1M Q4 '21: -63M Q1 '22: -74M Q2 '22: -80.2M Q3 '22: -85.3M Q4 '22: -86.2M Q1 '23: -80M Q2 '23: -71M Q3 '23: -61.8M Q4 '23: -55.5M Q1 '24: -54.7M Q2 '24: -52.3M Q3 '24: -50.4M Q4 '24: -51.5M Q1 '25: -49.4M Q2 '25: -49M Q3 '25: -46.1M Q4 '25: -38.4M Q1 '26: -37.3M Q2 '26: -29.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 5M 10M 15M Q3 '21: 9M Q4 '21: 8.6M Q1 '22: 9.3M Q2 '22: 9.8M Q3 '22: 10.6M Q4 '22: 12.4M Q1 '23: 12.4M Q2 '23: 13M Q3 '23: 12.8M Q4 '23: 11.9M Q1 '24: 11.6M Q2 '24: 11.3M Q3 '24: 11.8M Q4 '24: 11.6M Q1 '25: 11.2M Q2 '25: 11.2M Q3 '25: 10.6M Q4 '25: 10.7M Q1 '26: 11M Q2 '26: 10M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-90M -60M -30M 0 30M 60M 90M Q3 '21: -50.4M Q4 '21: -52.5M Q1 '22: -61.6M Q2 '22: -67.5M Q3 '22: -71.2M Q4 '22: -76M Q1 '23: -71.4M Q2 '23: -66.6M Q3 '23: -56.2M Q4 '23: -47.2M Q1 '24: -39.6M Q2 '24: -35.6M Q3 '24: -25.4M Q4 '24: -22.4M Q1 '25: -24.2M Q2 '25: -22.2M Q3 '25: -31.3M Q4 '25: -29.7M Q1 '26: -25.1M Q2 '26: -23.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-90M -60M -30M 0 30M 60M 90M Q3 '21: -51.3M Q4 '21: -53.4M Q1 '22: -62.6M Q2 '22: -68.5M Q3 '22: -72.2M Q4 '22: -76.9M Q1 '23: -72.3M Q2 '23: -67.2M Q3 '23: -56.9M Q4 '23: -48M Q1 '24: -40.4M Q2 '24: -36.3M Q3 '24: -25.9M Q4 '24: -22.7M Q1 '25: -24.4M Q2 '25: -22.6M Q3 '25: -31.8M Q4 '25: -29.9M Q1 '26: -25.4M Q2 '26: -23.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q3 '21: 39.8M Q1 '22: 47.6M Q2 '22: 47.7M Q3 '22: 47.9M Q1 '23: 48.4M Q2 '23: 48.5M Q3 '23: 48.7M Q1 '24: 49.5M Q2 '24: 49.9M Q3 '24: 50.3M Q1 '25: 51.3M Q2 '25: 51.8M Q3 '25: 52.4M Q1 '26: 53.9M Q2 '26: 54.5M Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q3 '21: -4.56 Q4 '21: -3.53 Q1 '22: -2.73 Q2 '22: -1.40 Q3 '22: -1.43 Q4 '22: -1.80 Q1 '23: -1.66 Q2 '23: -1.46 Q3 '23: -1.27 Q4 '23: -1.14 Q1 '24: -1.12 Q2 '24: -1.07 Q3 '24: -1.02 Q4 '24: -1.04 Q1 '25: -0.99 Q2 '25: -0.97 Q3 '25: -0.91 Q4 '25: -0.75 Q1 '26: -0.71 Q2 '26: -0.56 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.